PPAR-γ expression is suggestive of a tissue-specific cross-regulation, so that the ability of PPAR-γ agonists to downregulate cyclooxygenase-2 (COX-2) expression levels has been observed in breast cancer cells, macrophages, and colorectal cancer cells [26,39]. The gene discussed is PTGS2; the disease is breast cancer.